Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advil Migraine Liqui-Gels

This article was originally published in The Tan Sheet

Executive Summary

Commercial for the indication-specific analgesic breaks May 15 on network TV with the tagline "Start controlling the migraine before the migraine starts controlling you." Entitled "Tornado," the 30-second ad shows a woman suffering from a migraine standing in a field with a tornado. The ad was created by Young & Rubicam (New York City) and highlights the Advil line extension's unique delivery form, noting "Advil Migraine [is] the first and only FDA-approved migraine medicine in a liquid-filled form." Approved by the agency March 16, Whitehall-Robins began shipping the product April 24, joining McNeil Consumer Healthcare's Motrin Migraine Pain and Bristol-Myers Squibb's Excedrin Migraine in the new category

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

ID020288

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel